Finding Effective Treatments for COVID-19: Scientific Integrity and Public Confidence in a Time of Crisis

This Viewpoint discusses the risks posed by the FDA’s Emergency Use Authorization of chloroquine and hydroxychloroquine for COVID-19, and proposes principles to follow to ensure new therapies are studied properly and quickly to maximize benefits and minimize risks to patients.

Journal of the American Medical Association